152 related articles for article (PubMed ID: 30854098)
1. Downregulation of PDK4 Increases Lipogenesis and Associates with Poor Prognosis in Hepatocellular Carcinoma.
Yang C; Wang S; Ruan H; Li B; Cheng Z; He J; Zuo Q; Yu C; Wang H; Lv Y; Gu D; Jin G; Yao M; Qin W; Jin H
J Cancer; 2019; 10(4):918-926. PubMed ID: 30854098
[TBL] [Abstract][Full Text] [Related]
2. The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis.
Li G; Li M; Hu J; Lei R; Xiong H; Ji H; Yin H; Wei Q; Hu G
Oncogene; 2017 Feb; 36(7):989-998. PubMed ID: 27641336
[TBL] [Abstract][Full Text] [Related]
3. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation.
Grassian AR; Metallo CM; Coloff JL; Stephanopoulos G; Brugge JS
Genes Dev; 2011 Aug; 25(16):1716-33. PubMed ID: 21852536
[TBL] [Abstract][Full Text] [Related]
4. Loss of PDK4 expression promotes proliferation, tumorigenicity, motility and invasion of hepatocellular carcinoma cells.
Qin YJ; Lin TY; Lin XL; Liu Y; Zhao WT; Li XY; Lian M; Chen HW; Li YL; Zhang XL; Xiao D; Jia JS; Sun Y
J Cancer; 2020; 11(15):4397-4405. PubMed ID: 32489458
[TBL] [Abstract][Full Text] [Related]
5. Dual-tracer positron emission tomography/computed tomography as an imaging probe of
Tsao CH; Jhou RH; Ke CC; Chang CW; Chang CW; Yang BH; Huang WS; Shih BF; Liu RS
Front Med (Lausanne); 2022; 9():1008200. PubMed ID: 36237546
[TBL] [Abstract][Full Text] [Related]
6. Targeting PDK4 inhibits breast cancer metabolism.
Guda MR; Asuthkar S; Labak CM; Tsung AJ; Alexandrov I; Mackenzie MJ; Prasad DV; Velpula KK
Am J Cancer Res; 2018; 8(9):1725-1738. PubMed ID: 30323966
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Zhao Y; Li Z; Wang C
Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353
[TBL] [Abstract][Full Text] [Related]
9. lncRNA PCAT19 promotes the proliferation of laryngocarcinoma cells via modulation of the miR-182/PDK4 axis.
Xu S; Guo J; Zhang W
J Cell Biochem; 2019 Aug; 120(8):12810-12821. PubMed ID: 30868666
[TBL] [Abstract][Full Text] [Related]
10. microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect.
Han H; Li W; Shen H; Zhang J; Zhu Y; Li Y
J Mol Cell Biol; 2016 Oct; 8(5):400-410. PubMed ID: 27001970
[TBL] [Abstract][Full Text] [Related]
11. TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway.
Yin F; Sharen G; Yuan F; Peng Y; Chen R; Zhou X; Wei H; Li B; Jing W; Zhao J
Oncogenesis; 2017 Jun; 6(6):e347. PubMed ID: 28604762
[TBL] [Abstract][Full Text] [Related]
12. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
13. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
[TBL] [Abstract][Full Text] [Related]
14. Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.
Mo Y; Wu Y; Li X; Rao H; Tian X; Wu D; Qiu Z; Zheng G; Hu J
Eur J Pharmacol; 2020 Jan; 867():172788. PubMed ID: 31712058
[TBL] [Abstract][Full Text] [Related]
15. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4.
Deng YH; Deng ZH; Hao H; Wu XL; Gao H; Tang SH; Tang H
Exp Cell Res; 2018 Dec; 373(1-2):171-179. PubMed ID: 30342991
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate Dehydrogenase Kinase 4 Deficiency Increases Tumorigenesis in a Murine Model of Bladder Cancer.
Woolbright BL; Rajendran G; Abbott E; Martin A; Didde R; Dennis K; Harris RA; Taylor JA
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980540
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells.
Sun Y; Daemen A; Hatzivassiliou G; Arnott D; Wilson C; Zhuang G; Gao M; Liu P; Boudreau A; Johnson L; Settleman J
Cancer Metab; 2014; 2(1):20. PubMed ID: 25379179
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte pyruvate dehydrogenase kinase 4 expression is associated with augmented PPARĪ³ upregulation in early-life programming of later obesity.
Holness MJ; Zariwala G; Walker CG; Sugden MC
FEBS Open Bio; 2012; 2():32-6. PubMed ID: 23650578
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma.
Lin M; Lv D; Zheng Y; Wu M; Xu C; Zhang Q; Wu L
Onco Targets Ther; 2018; 11():3101-3110. PubMed ID: 29872321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
